Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

[Image: see text] The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is an urgent global need, thus different strategies targeting either virus or host cell are still under inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannalire, Rolando, Cerchia, Carmen, Beccari, Andrea R., Di Leva, Francesco Saverio, Summa, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688049/
https://www.ncbi.nlm.nih.gov/pubmed/33186044
http://dx.doi.org/10.1021/acs.jmedchem.0c01140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688049/
https://www.ncbi.nlm.nih.gov/pubmed/33186044
http://dx.doi.org/10.1021/acs.jmedchem.0c01140

Ejemplares similares